We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

Download Mobile App




Immune Cells Linked to Malaria-Induced Anemia Through Autoantibody Production

By LabMedica International staff writers
Posted on 28 Nov 2019
Malaria is still a major global health threat with over 200 million new infections and around 400,000 deaths per year. More...
Anemia is a common complication associated with malaria that contributes significantly to the great morbidity and mortality associated with the disease.

Despite its high clinical relevance, the mechanisms underlying malarial anemia in patients remain largely unknown. The difficulty in studying this syndrome arises at least in part from its multi-factorial etiology, as malaria causes both the clearance (through complement-mediated lysis or phagocytosis) of infected and uninfected erythrocytes and bone marrow dyserythropoiesis.

An international team of scientists led by those at New York University School of Medicine (New York City, NY, USA) recruited 24 patients who were aged between 18 and 65 years, and a diagnosis of Plasmodium falciparum malaria by microscopy. This cohort suffered from mild anemia with average hemoglobin levels of 12.4 g/dL (males) and 10.2 g/dL (females). Plasma and peripheral blood mononuclear cells (PBMC) were isolated from peripheral venous blood by Ficoll purification and stored at −80 °C until temperature-controlled transportation from Germany to the New York University. Peripheral venous blood from healthy malaria-naïve donors was obtained on the day of the study.

The scientists performed flow cytometry on a FACSCalibur (Becton Dickinson, Franklin Lakes, NJ, USA) and analyzed with FlowJo (Tree Star, Ashland, OR, USA). Intracellular T-bet staining was performed using the True-Nuclear Transcription Factor Buffer Set (Biolegend, San Diego, CA, USA). Enzyme-linked immunosorbent assays were performed to estimate malarial antibodies. Assessment of the erythrocyte lysis capacity of plasma was performed following previously described methods with small modifications. Supernatants were read in a spectrophotometer at 414 nm to assess erythrocyte lysis. ELISPOTs were performed as previously reported.

The team identified the production of an unusual type of immune B-cell: FcRL5+T-bet+ B-cells, that increases anti-phosphatidylserine (PS) antibody production associated with the development of anemia in the patients. These immune cells also developed and produced anti-PS antibodies in blood drawn from uninfected people that was then exposed to broken remnants of malaria-infected red blood cells in the laboratory.

Ana M. Rodriguez, PhD, a Professor of Microbiology and a senior author of the study, said, "There is a great need for novel targeted treatments for malaria-induced anemia, which is common and can be fatal for many malaria patients. The unique phenotype and specificity of these immune B-cells could allow them to be used as a biomarker for anemia or as a target for new therapies.” The study was published on November 12, 2019 in the journal eLife.

Related Links:
New York University School of Medicine
Becton Dickinson
Tree Star
Biolegend



New
Gold Member
Automated MALDI-TOF MS System
EXS 3000
Collection and Transport System
PurSafe Plus®
Human Estradiol Assay
Human Estradiol CLIA Kit
ESR Analyzer
TEST1 2.0
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Hematology

view channel
Image: New evidence shows viscoelastic testing can improve assessment of blood clotting during postpartum hemorrhage (Photo courtesy of 123RF)

Viscoelastic Testing Could Improve Treatment of Maternal Hemorrhage

Postpartum hemorrhage, severe bleeding after childbirth, remains one of the leading causes of maternal mortality worldwide, yet many of these deaths are preventable. Standard care can be hindered by delays... Read more

Industry

view channel
Image: The collaboration aims to improve access to Hb variant testing with the Gazelle POC diagnostic platform (Photo courtesy of Hemex Health)

Terumo BCT and Hemex Health Collaborate to Improve Access to Testing for Hemoglobin Disorders

Millions of people worldwide living with sickle cell disease and other hemoglobin disorders experience delayed diagnosis and limited access to effective care, particularly in regions where testing is scarce.... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.